Metabolites
Displaying metabolites 2451 - 2475 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB21651 | Dextrin 9004-53-9 | 2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol | Starch and sucrose metabolism PW000941 | 504.4371 C18H32O16 | |
ECMDB20547 | Diacetylchitobiose-6-phosphate | N-[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-[(phosphonooxy)methyl]oxan-2-yl]oxy}-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid | Chitobiose Degradation PW002042 | 504.3802 C16H29N2O14P | |
ECMDB20226 | 2-Hydroxydeoxyadenosine 5'-triphosphate | 6-amino-9-[4-hydroxy-5-({[hydroxy(phosphonatooxy)phosphoryl phosphonato]oxy}methyl)oxolan-2-yl]-9H-purin-2-olate | Collection of Reactions without pathways PW001891 | 503.1493 C10H12N5O13P3 | |
ECMDB23430 | 3-(all-trans-heptaprenyl)benzene-1,2-diol | 3-[(2E,5E,8E,11E,14E,17E)-3,6,9,12,15,18,21-heptamethyldocosa-2,5,8,11,14,17,20-heptaen-1-yl]benzene-1,2-diol | 502.7703 C35H50O2 | ||
ECMDB24743 | DG(10:0(3-OH)/16:0/0:0) | (2R)-2-hydroxy-3-[(3-hydroxydecanoyl)oxy]propyl hexadecanoate | phospholipid biosynthesis (CL(10:0(3-OH)/16:0/10:0(3-OH)/16:0)) PW001904 | 500.761 C29H56O6 | |
ECMDB24755 | DG(12:0(3-OH)/14:0/0:0) | (2R)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl tetradecanoate | phospholipid biosynthesis (CL(12:0(3-OH)/14:0/12:0(3-OH)/14:0)) PW001919 | 500.761 C29H56O6 | |
ECMDB24764 | DG(12:0/14:0(3-OH)/0:0) | (2S)-3-(dodecanoyloxy)-2-hydroxypropyl 3-hydroxytetradecanoate | phospholipid biosynthesis (CL(12:0/14:0(3-OH)/12:0/14:0(3-OH))) PW001931 | 500.761 C29H56O6 | |
ECMDB24768 | DG(14:0(3-OH)/12:0/0:0) | (2R)-3-(dodecanoyloxy)-2-hydroxypropyl 3-hydroxytetradecanoate | phospholipid biosynthesis (CL(14:0(3-OH)/12:0/14:0(3-OH)/12:0)) PW001935 | 500.761 C29H56O6 | |
ECMDB24774 | DG(14:0/12:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxydodecanoyl)oxy]propyl tetradecanoate | phospholipid biosynthesis (CL(14:0/12:0(3-OH)/14:0/12:0(3-OH))) PW001943 | 500.761 C29H56O6 | |
ECMDB24791 | DG(16:0/10:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxydecanoyl)oxy]propyl hexadecanoate | phospholipid biosynthesis (CL(16:0/10:0(3-OH)/16:0/10:0(3-OH))) PW001949 | 500.761 C29H56O6 | |
ECMDB23269 | DG(15:0/12:0/0:0) | (2R)-3-(dodecanoyloxy)-2-hydroxypropyl pentadecanoate | 498.789 C30H58O5 | ||
ECMDB23253 | DG(12:0/15:0/0:0) | (2S)-3-(dodecanoyloxy)-2-hydroxypropyl pentadecanoate | 498.789 C30H58O5 | ||
ECMDB24744 | DG(10:0(3-OH)/16:1(9Z)/0:0) | (2R)-2-hydroxy-3-[(3-hydroxydecanoyl)oxy]propyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis (CL(10:0(3-OH)/16:1(9Z)/10:0(3-OH)/16:1(9Z))) PW001903 | 498.745 C29H54O6 | |
ECMDB24750 | DG(10:0/17:0cycw7c/0:0) | (2S)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl decanoate | phospholipid biosynthesis (CL(10:0/17:0cycw7c/14:0/14:0)) PW001912 | 496.773 C30H56O5 | |
ECMDB24802 | DG(17:0cycw7c/10:0/0:0) | (2R)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl decanoate | phospholipid biosynthesis (CL(17:0cycw7c/10:0/14:0/14:0)) PW001968 | 496.773 C30H56O5 | |
ECMDB20024 | 1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene | (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-5-nitro-1,2-dihydronaphthalen-1-yl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid | glutathione metabolism II PW001927 | 496.491 C20H24N4O9S | |
ECMDB20025 | 1-Nitro-5-hydroxy-6-glutathionyl-5,6-dihydronaphthalene | (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-5-nitro-1,2-dihydronaphthalen-2-yl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid | glutathione metabolism II PW001927 | 496.491 C20H24N4O9S | |
ECMDB20026 | 1-Nitro-7-glutathionyl-8-hydroxy-7,8-dihydronaphthalene | (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-8-nitro-1,2-dihydronaphthalen-2-yl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid | glutathione metabolism II PW001927 | 496.491 C20H24N4O9S | |
ECMDB20027 | 1-Nitro-7-hydroxy-8-glutathionyl-7,8-dihydronaphthalene | (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-8-nitro-1,2-dihydronaphthalen-1-yl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid | glutathione metabolism II PW001927 | 496.491 C20H24N4O9S | |
ECMDB01144 | Dihydroneopterin triphosphate 20574-65-6 | {[({[(2R,3S)-3-(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}phosphonic acid | Folate biosynthesis PW000908 | 495.1703 C9H16N5O13P3 | |
ECMDB20429 | Hydroxymethyl-dCTP | 1-[(2S,4S,5S)-4-hydroxy-5-({[hydroxy({[hydroxy(phosphonatooxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-2-yl]-5-(hydroxymethyl)-2-oxo-1,2-dihydropyrimidin-4-olate | 495.1438 C10H14N2O15P3 | ||
ECMDB20549 | Dihydromonapterin-triphosphate | 6-[(1S,2S)-3-[({[(hydrogen phosphonatooxy)phosphinato]oxy}phosphinato)-λ³-oxidanyliumyl]-1,2-dihydroxypropyl]-4-hydroxy-2-iminiumyl-2,7-dihydro-1H-5λ⁵-pteridin-8-ium-5-ylium | Tetrahydromonapterin Biosynthesis PW002043 | 493.1544 C9H14N5O13P3 | |
ECMDB20562 | GMP-Lysine | 9-[(2R,3R,4S,5R)-5-{[({[(2R)-2,6-diazaniumylhexanoyl]oxy}(hydroxy)phosphoryl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-6-hydroxy-2-imino-3,9-dihydro-2H-7λ⁵-purin-7-ylium-3-id-7-yl | 492.4008 C16H27N7O9P | ||
ECMDB23796 | L-Threonylcarbamoyladenylate | (2S,3R)-2-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)methylidene}amino)-3-hydroxybutanoic acid | 492.3346 C15H21N6O11P | ||
ECMDB04063 | 2'-Deoxyinosine triphosphate 16595-02-1 | {[hydroxy({[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphoryl]oxy}phosphonic acid | 492.1664 C10H15N4O13P3 |